Béatrice Nawrocki-Raby

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 23, 2024
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies.

Emma Loeffler, Julien Ancel, Véronique Dalstein

|Jul 24, 2021
Hypoxia in Lung Cancer Management: A Translational Approach.

Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf

|Apr 30, 2021
Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells.

Anda Huna, Béatrice Nawrocki-Raby, Teresita Padilla-Benavides

|Apr 03, 2020
FHITlow /pHER2high signature in non-small cell lung cancer is predictive of anti-HER2 molecule efficacy.

Jordan Da Silva, Amina Jouida, Julien Ancel

Pageof 1